Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Erickson

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Journal of Autism and Developmental Disorders|December 15, 2023
Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum DisorderCraig A Erickson, Rebecca C Shaffer, Meredith Will, et al.
Frontiers in Integrative Neuroscience|October 26, 2019
Auditory EEG Biomarkers in Fragile X Syndrome: Clinical RelevanceLauren E Ethridge, Lisa A De Stefano, Lauren M Schmitt, et al.
Journal of Autism and Developmental Disorders|September 26, 2023
Patterns in Medication Use for Treatment of Depression in Autistic Spectrum DisorderRiley A Argonis, Ernest V Pedapati, Kelli C Dominick, et al.
Biomarkers in Neuropsychiatry|May 31, 2024
Reliability of resting-state electrophysiology in fragile X syndromeRui Liu, Ernest V Pedapati, Lauren M Schmitt, et al.
Nature Neuroscience|November 17, 2018
Author Correction: Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversibleAnubhuti Goel, Daniel A Cantu, Janna Guilfoyle, et al.
Nature Neuroscience|July 26, 2023
Author Correction: Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversibleAnubhuti Goel, Daniel A Cantu, Janna Guilfoyle, et al.
Brain Sciences|December 19, 2018
Best Practices in Fragile X Syndrome Treatment DevelopmentCraig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
American Journal of Medical Genetics. Part A|July 30, 2015
The neurobehavioral and molecular phenotype of Angelman SyndromeLogan K Wink, Sarah Fitzpatrick, Rebecca Shaffer, et al.
Nature Neuroscience|September 26, 2018
Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversibleAnubhuti Goel, Daniel A Cantu, Janna Guilfoyle, et al.
Journal of Neurodevelopmental Disorders|September 27, 2022
Baclofen-associated neurophysiologic target engagement across species in fragile X syndromeCarrie R Jonak, Ernest V Pedapati, Lauren M Schmitt, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Journal of Autism and Developmental Disorders|December 15, 2023
Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum DisorderCraig A Erickson, Rebecca C Shaffer, Meredith Will, et al.
Frontiers in Integrative Neuroscience|October 26, 2019
Auditory EEG Biomarkers in Fragile X Syndrome: Clinical RelevanceLauren E Ethridge, Lisa A De Stefano, Lauren M Schmitt, et al.
Journal of Autism and Developmental Disorders|September 26, 2023
Patterns in Medication Use for Treatment of Depression in Autistic Spectrum DisorderRiley A Argonis, Ernest V Pedapati, Kelli C Dominick, et al.
Biomarkers in Neuropsychiatry|May 31, 2024
Reliability of resting-state electrophysiology in fragile X syndromeRui Liu, Ernest V Pedapati, Lauren M Schmitt, et al.
Nature Neuroscience|November 17, 2018
Author Correction: Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversibleAnubhuti Goel, Daniel A Cantu, Janna Guilfoyle, et al.
Nature Neuroscience|July 26, 2023
Author Correction: Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversibleAnubhuti Goel, Daniel A Cantu, Janna Guilfoyle, et al.
Brain Sciences|December 19, 2018
Best Practices in Fragile X Syndrome Treatment DevelopmentCraig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
American Journal of Medical Genetics. Part A|July 30, 2015
The neurobehavioral and molecular phenotype of Angelman SyndromeLogan K Wink, Sarah Fitzpatrick, Rebecca Shaffer, et al.
Nature Neuroscience|September 26, 2018
Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversibleAnubhuti Goel, Daniel A Cantu, Janna Guilfoyle, et al.
Journal of Neurodevelopmental Disorders|September 27, 2022
Baclofen-associated neurophysiologic target engagement across species in fragile X syndromeCarrie R Jonak, Ernest V Pedapati, Lauren M Schmitt, et al.
Pageof 16